Hormone Therapy Market Growth Outlook: Why Analysts Expect Continued Expansion
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Hormone Therapy Market Growth From $22.44 Billion In 2026 To $29.93 Billion By 2030 At A CAGR Of 7.5%
The hormone therapy market has experienced significant expansion in recent years. This market is projected to grow from $20.9 billion in 2025 to $22.44 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.4%. Historically, the market’s growth can be attributed to the rising prevalence of hormonal disorders, increased awareness of hormone replacement therapy, higher rates of hypothyroidism diagnosis, the expansion of hospital pharmacy networks, and the availability of low-cost generic hormones.
The hormone therapy market is projected to experience substantial expansion in the coming years. This market is predicted to reach $29.93 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.5%. Key factors driving this growth during the projected timeframe include the global aging demographic, an increase in treatments related to menopause, a heightened emphasis on therapies aimed at improving quality of life, the expanding reach of online pharmacies, and continuous advancements in hormone delivery methods. Significant trends anticipated for the forecast period encompass a greater acceptance of personalized hormone treatment plans, an escalating need for bioidentical hormones, the broader application of hormone therapy among older demographics, a rise in the utilization of combined hormone therapies, and a move towards more user-friendly and extended-release formulations.
Get A Free Sample Report With In-Depth Market Insights:
Hormone Therapy Market Development Factors: What’s Supporting Demand?
The rising population of older people is anticipated to boost the expansion of the hormone therapy market over the next few years. Elderly individuals are those in advanced stages of life, commonly referred to as older persons or the senior demographic. For older adults, especially concerning health issues linked to aging, hormone treatment seeks to rectify hormonal disparities and address particular age-related conditions. An illustration of this trend is found in the UK: in July 2024, the UK Parliament, a governmental organization, projected the UK’s population to hit 70 million by 2026. Furthermore, the country’s population is experiencing an aging trend, with 19% of individuals being 65 years or older in 2022. This percentage is forecast to increase to 27% by 2072. Consequently, the growing demographic of elderly individuals is fueling the hormone therapy market.
Hormone Therapy Market Segmentation: How Does The Market Break Down By Category?
The hormone therapy market covered in this report is segmented –
1) By Therapy: Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, Testosterone Replacement
2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
3) By Indication: Menopause, Hypothyroidism, Growth Hormone Deficiency, Other Indications
4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies And Stores, Online Pharmacies
Subsegments:
1) By Estrogen Hormone Replacement: Systemic Estrogen Therapy, Local Estrogen Therapy, Combination Estrogen-Progestin Therapy
2) By Growth Hormone Replacement: Recombinant Growth Hormones, Synthetic Growth Hormones
3) By Thyroid Hormone Replacement: Levothyroxine, Liothyronine, Natural Desiccated Thyroid
4) By Testosterone Replacement: Injectable Testosterone, Transdermal Testosterone, Oral Testosterone, Pellets
Hormone Therapy Market Transformation Trends: What Innovations Are Driving Change?
Leading firms within the hormone therapy market are concentrating on creating novel approaches, including direct-to-consumer telehealth systems for hormone therapy, with the aim of improving patient access and ease of use. This direct-to-consumer telehealth paradigm for hormone therapy describes a healthcare service delivery method where individuals can obtain hormone therapy remotely, bypassing conventional in-person doctor visits. As an illustration, in September 2023, LifeMD, a US-based telehealth provider, collaborated with ASCEND Therapeutics, a US-based pharmaceutical entity, to introduce a unified direct-to-consumer telehealth framework for hormone therapy, specifically utilizing EstroGel (estradiol gel) to ease menopausal discomfort. Through this alliance, patients can directly engage with LifeMD’s telehealth offerings via the EstroGel website, enabling virtual consultations with certified healthcare professionals who can issue prescriptions and organize direct home delivery of the medicine. This endeavor seeks to improve health results for women pursuing menopause treatment by simplifying accessibility and overcoming obstacles like extended waiting periods.
Hormone Therapy Market Competitive Overview And Top Companies
Major companies operating in the hormone therapy market are Abbott Laboratories, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche, Merck KGaA, Mylan NV, Novartis AG, Novo Nordisk AS, Pfizer Inc., Abbvie Inc., Teva Pharmaceutical Industries Ltd., Perrigo Company Plc., Cipla Inc., Lupin Limited, Sun Pharmaceuticals Industries Ltd., Hikma Pharmaceuticals PLC., Johnsons & Johnsons Services Inc., Boehringer Ingelheim International GmbH, Sanofi S.A., AstraZeneca plc, TherapeuticsMD Inc., Amgen Inc., Genentech Inc., Dr. Reddy’s Laboratories Ltd, Allergan PLC, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Daiichi Sankyo Company Limited
View The Full Hormone Therapy Market Report:
Hormone Therapy Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the hormone therapy market in 2025. The regions covered in the hormone therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
